Introduction
============

Tuberculosis (TB) is an infectious disease caused by various strains of mycobacteria, usually *mycobacterium tuberculosis* (Mtb) in humans. According to World Health Organization (WHO) report, about one-third of the current global population is infected asymptomatically with Mtb, of whom 10% will develop clinical disease during their lifetime [@B1]. The difference between infection rate and incidence rate may be caused by smoking history, physical condition, genetic factor, socio-economic factor, and health resource allocation factor [@B2]. Significant difference in the incidence of TB in different regions, ethnic groups, and populations also proved that genetic factor is responsible for TB susceptibility. The highest incidence of TB is in Asia (58%), followed by Africa (27%), the Eastern Mediterranean Region (8%), the European Region (4%), and the Region of the Americas (3%) [@B2]. China has the world\'s second largest TB epidemic, and the epidemic in the Western China is higher than the national average [@B3]. The active TB incidence of the Uygur, Kazak, and Mongolian populations in Western China was found to be 2.39 times higher than the Chinese Han in Eastern China. These facts together with other substantial evidence indicate that host genetic factors may play an important role in TB susceptibility, which contains single nucleotide polymorphisms (SNP) as a major factor. Numerous studies have been performed on the association of genetic variants with TB susceptibility including *TLR 2* [@B4], *CTLA 4*[@B5], *MRC1*[@B6], and *PTPN22*[@B7] SNPs.

Innate immunity is the first line of defense against Mtb. Pattern recognition receptors (PRRs) can recognize pathogen-associated molecular patterns of Mtb, causing macrophages activation and triggers an immune response. Toll-like receptors (TLR) and NOD-like receptors (NLR) are two main kinds of PRRs. NOD2 is a member of the NLR family located on chromosome 16q21. It has been shown to recognize muramyl dipeptide (MDP), a component of bacterial cell wall peptidoglycan (PGN), by Leucine-rich repeat (LRR) region. Upon recognition of agonist, NOD2 self-oligomerize to activate RICK via CARD-CARD interactions. RICK is then able to activate the IKK complex, which in turn activate NF-κB that ultimately induces pro-inflammatory cytokine transcription to clear intracellular bacteria [@B8]. Austin et al. [@B9] sequenced *NOD2* gene and found that Pro268Ser, Arg702Trp, and Ala725Gly were significantly associated with TB disease. Pro268Ser was found to be a susceptible SNP that can lead to nucleotide mutation resulting in amino acid changes, thereby changing the protein structure, thus affecting African Americans\' TB incidence. But, no association between Arg702Trp, Gly908Arg and 3020insC of the *NOD2* gene and TB was found in the Gambia population [@B10].

Many studies have reported the association between *NOD2* polymorphisms and TB. However, the results are inconsistent and inconclusive due to limited sample sizes and different study populations. Therefore, in this article, we performed a systematic review and meta-analysis, based on literature identification until 17^th^ July 2013 to summarize the associations between these polymorphisms and TB susceptibility.

Materials and Methods
=====================

Selection of Studies in Meta-analysis
-------------------------------------

We searched the PubMed, Ovid, ISI Web of Knowledge, Elsevier ScienceDirect, and Chinese National Knowledge Infrastructure (CNKI) to identify studies of the association between TB susceptibility and NOD2 polymorphisms until 17^th^ July 2013. The key words were: \'Mycobacterium tuberculosis\' or \'tuberculosis\' in combination with \'polymorphism\' or \'variant\' or \'genotype\' or \'allele\' or \'mutation\', in combination with \'Nucleotide binding oligomerization domain containing 2\' or \'NOD2\' or \'CARD15\' or \'CD\' or \'ACUG\' or \'BLAU\' or \'IBD1\' or \'NLRC2\' or \'NOD2B\' or \'CLR16.3\' or \'PSORAS1\'. The search results were limited to English and Chinese language articles. All retrieved titles and abstracts were examined for relevant studies. Inclusion criteria of our study were: 1) case control studies of unrelated individuals; 2) evaluation of *NOD2* polymorphisms and TB susceptibility; 3) genotype distribution in both cases and controls were available. Exclusion criteria were: 1) study design based on family or sibling pairs; 2) genotype frequencies not reported; and 3) data from reviews and abstracts. Additional studies were also identified by hand searching reference lists of original studies and review articles including meta-analysis. The systematic review process is described in the flowchart of Figure [1](#F1){ref-type="fig"}.

Data Extraction
---------------

All of the publications were assessed independently by two reviewers. For all studies, two reviewers extracted the following data from original publications: first author and year of publication; distribution of genotypes for each polymorphism among cases and controls; characteristics of the study design and the study population (study base, numbers and mean age of cases and controls, TB diagnosis, HIV status, source of controls, matching criteria and host ethnicity).

Bias Exclusion
--------------

Publication bias was evaluated by Begg\'s test and Egger\'s test [@B11], [@B12]. Bias in location of studies, English language bias, and database bias was excluded by searching both English and Chinese database.

Statistical Analyses
--------------------

Hardy-Weinberg Equilibrium (HWE) was examined in controls by asymptotic Pearson\'s Chi-square test for each polymorphism in each study. The association between polymorphism and TB was estimated by means of odds ratios (OR) and corresponding 95% confidence intervals (CI) comparing cases to controls. Study heterogeneity was tested by the Q test and I^2^ test [@B13], and the heterogeneity was considered significant if *P*-value was less than 0.05 or I^2^\> 50%. Fixed-effects models were adopted when *P*-value was more than 0.05; otherwise random-effects models were used. Statistical analyses were carried out using the Stata/SE 12.0 (College Station, TX, USA) and the Review Manager 5.1 software (Oxford, England).

Results
=======

Characteristics of Included Studies
-----------------------------------

A total of 240 articles were achieved by literature search. As shown in Figure [1](#F1){ref-type="fig"}, after excluding those overlapped abstracts between the databases, 177 abstracts were retrieved for detailed evaluation. Six articles were left after removing 171 unsuitable articles, and one of them was excluded because its SNP was only once reported. Finally, 7 studies from 5 articles [@B9], [@B10], [@B14]-[@B16] were included in this review and meta-analysis. Among them, there were four studies for *NOD2* Arg587Arg, seven studies for *NOD2* Arg702Trp, and four studies for *NOD2* Gly908Arg. Otherwise, there was only one study for SNPs such as Ala140Thr, Pro268Ser, Val955Ile, and 3020insC, which was eliminated. As shown in Table [1](#T1){ref-type="table"}, the study participants were from diverse descents including American, African, and Asian. The pooled sample size was 3,706 (2,215 cases and 1,491 controls). The genotype and allele distributions of all the polymorphisms are shown in Table [2](#T2){ref-type="table"}.

Quantitative Data Synthesis
---------------------------

### *NOD2* Arg587Arg polymorphism

Four case-control studies (802 cases and 567 controls) on the relationship between the *NOD2* Arg587Arg polymorphisms and the risk of TB were analyzed. We analyzed the heterogeneity of G vs. T for all studies and the value of χ^2^ was 5.90 with 2 degrees of freedom and *P*= 0.05. I^2^, another index of the test of heterogeneity, was 66%, suggesting a high heterogeneity. Thus, we chose the random-effect model to synthesize the data. Overall, no association was found in the allelic frequency with TB risk (OR = 1.31, 95% CI = 0.83-2.07, *P* = 0.25) (Figure [2](#F2){ref-type="fig"}A).

### *NOD2* Arg702Trp polymorphism

Seven case-control studies (2,215 cases and 1,491 controls) were included in the meta-analysis on the relationship between the *NOD2* Arg702Trp polymorphisms and the risk of TB. As shown in Figure [2](#F2){ref-type="fig"}B, the heterogeneity of T vs. C for all the studies was analyzed. The χ^2^ value was 1.14, with 1 df and *P* = 0.28, while I^2^ was 13%, suggesting a low heterogeneity. Thus, we chose the fixed-effect model, and found that the individuals who carried the T allele may have a decreased risk of TB (OR = 0.43, 95% CI = 0.20-0.90, *P* = 0.02) (Figure [2](#F2){ref-type="fig"}B).

### *NOD2*Gly908Arg polymorphism

Four case-control studies (1,392 cases and 1,111 controls) on the relationship between the *NOD2* Gly908Arg polymorphisms and the risk of TB were included in the meta-analysis. The results on this polymorphism indicated that the C allele had no significant association to TB susceptibility as compared to the G allele under the fixed-effects models (OR = 0.78, 95% CI = 0.21-2.87, *P* = 0.71) (Figure [2](#F2){ref-type="fig"}C).

### Publication Bias

Publication bias was analyzed by using the Begg\'s test and Egger\'s test. The publication bias by Begg\'s test showed no significant publication bias in *NOD2* Arg587Arg, Arg702Trp, and Gly908Arg (*P*= 1.000, *P*= 1.000, *P*= 1.000). Then, Egger\'s test was also used. For *NOD2* Arg587Arg polymorphism, the *P* value of Egger\'s test was 0.520. The results still did not suggest any evidence of publication bias.

### Sensitivity Analysis

Sensitivity analysis was performed by sequentially excluding individual studies. After sequentially excluding each case-control study, statistically similar results were obtained for G vs. T of Arg587Arg, T vs. C of Arg702Trp, and C vs. G of Gly908Arg, indicating that our data were stability and liability in this meta-analysis.

Discussion
==========

In this study, we found that *NOD2* SNPs show different effects on the incidence of TB. The meta-analysis revealed an association between the Arg702Trp T allele and TB protection. At the same time, different ethnicity groups contribute to different TB susceptibility, such as Arg587Arg G allele is a TB risk SNP in Chinese Han while having no association with Kazak and Uygur. However, the Gly908Arg polymorphism did not show significant association with TB.

NOD2 is a kind of PRRs, which can identify Mtb invasion in cells. A recent report indicates that NOD2 and TLR pathways are non-redundant in the recognition of Mtb, but can synergize to induce a robust pro-inflammatory response [@B17]. In addition, it has been shown in bone marrow-derived murine macrophages (BMMs) that RIP2 polyubiquitination occurs during Mtb incubation in a NOD2-dependent manner [@B18]. Brooks et al. [@B19] also found that NOD2 in human macrophages can not only control the pro-inflammatory cytokine response, but also control the proliferation of Mtb. According to the importance of NOD2 in Mtb infection, we suggested that Arg587Arg, Arg702Trp, and Gly908Arg polymorphisms may be associated with TB susceptibility.

Arg587Arg is located on the winged helix and superhelical domain of the NOD2 protein coding by exon 4 and linked to the NACHT domain for synonymous mutation. Sato et al. [@B20] found that Arg587Arg G allele was associated with significantly better lung function in pulmonary sarcoidosis. In addition, Arg587Arg G allele has also been found to be a protective site of inflammatory bowel disease [@B21]. Several studies have revealed a substantial contribution of synonymous SNPs to human disease risk [@B22]. We suggested that Arg587Arg may be associated with susceptibility to TB in the Chinese Han population. However, in our meta-analysis, Arg587Arg GT genotype is a TB risk factor in Chinese Han, but not in Kazak and Uygur, with the fact that this SNP even do not exist in African Americans. The reasons for the difference were unclear, but the differences in the polymorphisms frequency and the differences in the infected Mtb strains might contribute to this heterogeneity.

Arg702Trp is also located in the exon 4, a missense mutation coding for LRR. Austin et al. [@B9] showed that the C to T change on Arg702Trp is a protective factor for African Americans, but, Möller et al. [@B15] indicated that the site has nothing to do with the incidence of TB in South Africa. In this meta-analysis, we found that Arg702Trp is a protective factor for the incidence of TB (OR = 0.43, 95% CI = 0.20-0.90, *P* = 0.02), although it appears only in the African population in limited articles. This SNP can lead to an amino acid changes, from a low hydrophobic arginine to a high hydrophobic tryptophan. Articles showed Arg702Trp did not change the membrane localization function of NOD2 protein [@B23], with the normal MDP-induced NF-κB activation [@B24]. Because of the location of Arg702Trp, we speculated that Arg702Trp could reinforce the LRR combination with MDP, making it easier to clear intracellular Mtb.

Gly908Arg is also a missense mutation coding for LRR, which is located in the exon 8. Literature showed that Gly908Arg expressed in HEK293T cells reveals defects in NF-κB transcription [@B25], [@B26], leading to a broadly impaired transcriptional response and impaired cytokine, and co-stimulatory protein induction with MDP stimulation [@B27], [@B28], thus affecting bacterial diseases. Existing literature suggest that Gly908Arg is associated with Crohn\'s disease in the Dutch [@B29], Swedish [@B30], and Italian [@B31] populations. However, there was no such association with TB, which is reconfirmed by our meta-analysis.

However, there are still some limitations in our meta-analysis that should be considered when explaining the present results. Firstly, we did not track the unpublished articles to obtain data for analysis. The potential effect of this publication bias is unknown. Secondly, due to the limited number of studies, there are some SNPs such as 3020insC that were not included in this systematic analysis. Thirdly, the small sample sizes in some subgroup analyses may have limited statistical power to estimate the possible risk for *NOD2* polymorphisms.

In conclusion, this systematic review summarized the association between *NOD2*polymorphisms and TB susceptibility. Our results indicated that *NOD2* Arg702Trp polymorphism is likely to be the protective allele. However, the Arg587Arg and Gly908Arg polymorphisms might not be the genetic risk factors for TB susceptibility, knowing the fact that Arg587Arg is only a risk factor in Chinese Han. More studies with a larger group of populations should be performed, especially in Caucasians.
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###### 

Characteristics of the 7 studies included in the meta-analysis.

  Author           Year   Country                  Ethnicity           Age, years mean ± SD or mean (range)   Samples, n      Genotying method         
  ---------------- ------ ------------------------ ------------------- -------------------------------------- --------------- ------------------ ----- -------------------------------
  Austin et al     2007   United States            African Americans   46.5 ± 12.9                            45.4 ± 10.6     377                187   PCR-sequencing
  Möller et al     2006   South Africa             South Africans      34 ± 14.8                              27 ± 12.3       432                482   Taq Man SNP genotyping assays
  Singh et al      2012   Northern Indian states   Indians             33.18 ± 13.29                          36.85 ± 12.6    263                122   PCR-RFLP
  Stockton et al   2004   Gambia                   Gambians            36 (19-58)                             32 (18-50)      320                320   PCR-RFLP, PCR-FRET
  Zhao et al_a     2012   China                    Chinese Han         36.47 ± 15.73                          37.02 ± 15.29   219                215   PCR-sequencing
  Zhao et al_b     2012   China                    Chinese Uygur       28.8 ± 10.1                            30.1 ± 8.9      86                 72    PCR-sequencing
  Zhao et al_c     2012   China                    Chinese Kazak       28.8 ± 10.1                            37.02 ± 15.29   120                93    PCR-sequencing

PCR = polymerase chain reaction; RFLP = restriction fragment length polymorphism; FRET = fluorescence resonance energy transfer.

###### 

Genotype and allele distribution of *NOD2* polymorphisms in TB and controls.

  SNP                Study            Cases                                      Controls                                     HWE P
  ------------------ ---------------- -------- -------- -------- ------- ------- ---------- -------- -------- ------- ------- -------
  *NOD2* Arg587Arg   Austin et al     377      0        0        754     0       187        0        0        374     0       /
                     Zhao et al_a     160      53       4        377     61      185        28       2        398     32      0.423
                     Zhao et al_b     49       29       8        127     45      37         29       6        103     41      0.925
                     Zhao et al_c     65       147      8        177     63      56         32       5        144     42      0.878
                                      **CC**   **CT**   **TT**   **C**   **T**   **CC**     **CT**   **TT**   **C**   **T**   
  *NOD2* Arg702Trp   Austin et al     372      5        0        749     5       187        9        0        365     9       0.742
  rs2066844          Möller et al     421      6        0        848     6       468        11       0        947     11      0.799
                     Singh et al      263      0        0        526     0       122        0        0        244     0       /
                     Stockton et al   192      0        0        384     0       192        0        0        384     0       /
                     Zhao et al_a     217      0        0        434     0       215        0        0        430     0       /
                     Zhao et al_b     86       0        0        172     0       72         0        0        144     0       /
                     Zhao et al_c     120      0        0        240     0       93         0        0        186     0       /
                                      **GG**   **GC**   **CC**   **G**   **C**   **GG**     **GC**   **CC**   **G**   **C**   
  *NOD2* Gly908Arg   Austin et al     377      0        0        754     0       187        0        0        374     0       /
  rs2066845          Möller et al     426      2        0        854     2       476        4        0        956     4       0.927
                     Singh et al      260      3        0        523     3       121        1        0        243     1       0.926
                     Stockton et al   192      0        0        384     0       192        0        0        384     0       /

HWE: Hardy-Weinberg Equilibrium.
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